Indian industry warns of 'incapacitating' effect of large foreign takeovers
This article was originally published in Scrip
Executive Summary
Second rung Indian firms, which account for less than 20% of the country's pharmaceutical exports, cannot fill the shoes of first tier companies if the latter continue to be acquired by foreign firms, a leading domestic industry body has told a government committee looking into issues concerning India's foreign direct investment (FDI) policy in the sector.